Literature DB >> 16609989

Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.

Bing Luo1, Yun Wang, Xiao-Feng Wang, Yu Gao, Bao-Hua Huang, Peng Zhao.   

Abstract

AIM: To investigate the interrelationship of Epstein-Barr virus (EBV) and EBV- encoded proteins with Helicobacter pylori (H pylori) infection and the expression of c-met and c-myc oncogene proteins in gastric carcinoma, and to explore their role in gastric carcinogenesis.
METHODS: One hundred and eighty-five gastric carcinoma tissues were detected by polymerase chain reaction (PCR)-Southern blot for EBV genome and in situ hybridization (ISH) for EBV-encoded small RNA 1 (EBER1). Gastric carcinoma with positive EBER1 signals was confirmed EBV-associated gastric carcinoma (EBVaGC). The status of H pylori infection in 185 gastric carcinomas was assessed by rapid urease test and PCR. The samples with positive PCR and urease test were defined as H pylori infection. The expression of c-met and c-myc oncogene proteins in tissues of EBVaGC and matched EBV-negative gastric carcinoma (EBVnGC) were examined by immunohistochemistry. RT-PCR and Southern hybridization were used to detect the expression of nuclear antigens (EBNAs) 1 and 2, latent membrane protein (LMP) 1, early genes BARF1 and BHRF1 in EBVaGC cases.
RESULTS: The positive rate of H pylori and EBV in 185 gastric carcinomas was 59.45% (110/185) and 7.03% (13/185) respectively. No difference was found in sex, age, pathological differentiation, clinical stages and lymph node metastasis between H pylori-positive and H pylori-negative gastric carcinomas. However, the positive rate of H pylori infection in the antrum gastric carcinomas was higher than that of cardia and body gastric carcinomas. In our series, age, pathological differentiation, clinical stages, lymph node metastasis and location of cancer were not different between EBVnGC and EBVaGC, while the positive rate of EBV in male patients was significantly higher than that of female patients. The positivity of H pylori in EBV-associated and EBV-negative gastric carcinomas was 46.15% (6/13) and 81.40%(104/172) respectively. There was no significant correlation between EBV and H pylori infection. The c-met overexpression was significantly higher in the EBVaGC group than in the EBVnGC group. However, c-met and c-myc expression did not show significant difference between the two groups. Transcripts of EBNA1 were detected in all 13 EBVaGCs, while both EBNA2 and LMP1 mRNA were not detected. Six of the 13 cases exhibited BARF1 transcripts and 2 exhibited BHRF1 transcripts.
CONCLUSION: The positivity of H pylori in EBVnGCs is higher than that of EBVaGCs, but no significant correlation is found between EBV infection and H pylori infection. H pylori-positive gastric carcinoma is predominant in antrum location, while EBVaGC has a tendency of predominance in cardia/body location. EBV infection is associated with c-met abnormal expression but not with c-myc protein in EBVaGC. c-met overexpression is not induced by LMP1. BARF1 and BHRF1 may play important roles in the tumorigenesis of EBVaGC through different pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609989      PMCID: PMC4087508          DOI: 10.3748/wjg.v12.i12.1842

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  EBV-associated neoplasms: alternative pathogenetic pathways.

Authors:  Hans Helmut Niller; Daniel Salamon; Karin Ilg; Anita Koroknai; Ferenc Banati; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538

2.  Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.

Authors:  Qiulong Huang; Andrew M Petros; Herbert W Virgin; Stephen W Fesik; Edward T Olejniczak
Journal:  J Mol Biol       Date:  2003-10-03       Impact factor: 5.469

3.  Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals.

Authors:  S A Ho; J A Hoyle; F A Lewis; A D Secker; D Cross; N P Mapstone; M F Dixon; J I Wyatt; D S Tompkins; G R Taylor
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus.

Authors:  Wang Sheng; Gisèle Decaussin; Audrey Ligout; Kenzo Takada; Tadamasa Ooka
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

Authors:  L E Hansson; L Engstrand; O Nyrén; D J Evans; A Lindgren; R Bergström; B Andersson; L Athlin; O Bendtsen; P Tracz
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

6.  Gastric carcinoma with lymphoid stroma: incidence of EBV and Helicobacter pylori infection.

Authors:  Hye Jae Cho; Jung Yeon Kim; Jinye Yoo; Sang Sook Lee
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-06

7.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

Authors:  L Naldini; E Vigna; R P Narsimhan; G Gaudino; R Zarnegar; G K Michalopoulos; P M Comoglio
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

8.  The Epstein Barr virus and gastric carcinoma.

Authors:  N Andal; P Shanthi; K Baba Krishnan; V Taralaxmi
Journal:  Indian J Pathol Microbiol       Date:  2003-01       Impact factor: 0.740

9.  Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.

Authors:  Martin Schlee; Tanja Krug; Olivier Gires; Reinhard Zeidler; Wolfgang Hammerschmidt; Reinhard Mailhammer; Gerhard Laux; Guido Sauer; Josip Lovric; Georg W Bornkamm
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer.

Authors:  Myung Ah Lee; Young Seon Hong; Jin Hyoung Kang; Kyung Shik Lee; Jin Young You; Kyo Young Lee; Cho Hyun Park
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884

View more
  16 in total

1.  EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Authors:  Helene Geddert; Axel zur Hausen; Helmut E Gabbert; Mario Sarbia
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

2.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

3.  E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance.

Authors:  Chihaya Koriyama; Suminori Akiba; Tetsuhiko Itoh; Kazunobu Sueyoshi; Yoshie Minakami; Alejandro Corvalan; Suguru Yonezawa; Yoshito Eizuru
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

Review 4.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.

Authors:  Valeska Portela Lima; Marcos Antonio Pereira de Lima; Angela Rosa André; Márcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Sílvia Helena Barem Rabenhorst
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

6.  Epstein-Barr virus-specific methylation of human genes in gastric cancer cells.

Authors:  Julie L Ryan; Richard J Jones; Shannon C Kenney; Ashley G Rivenbark; Weihua Tang; Elizabeth Rw Knight; William B Coleman; Margaret L Gulley
Journal:  Infect Agent Cancer       Date:  2010-12-31       Impact factor: 2.965

7.  Graph theory enables drug repurposing--how a mathematical model can drive the discovery of hidden mechanisms of action.

Authors:  Ruggero Gramatica; T Di Matteo; Stefano Giorgetti; Massimo Barbiani; Dorian Bevec; Tomaso Aste
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 8.  Metabolic Control by DNA Tumor Virus-Encoded Proteins.

Authors:  Martin A Prusinkiewicz; Joe S Mymryk
Journal:  Pathogens       Date:  2021-05-06

9.  Epstein-Barr virus-associated gastric carcinoma in Brazil: comparison between in situ hybridization and polymerase chain reaction detection.

Authors:  Marcos Antonio Pereira de Lima; Márcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês de Moura Campos Pardini; Adriana Camargo Ferrasi; Silvia Helena Barem Rabenhorst
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Helicobacter pylori genotypes associated with gastric histo-pathological damages in a Moroccan population.

Authors:  Samia Alaoui Boukhris; Afaf Amarti; Karima El Rhazi; Mounia El Khadir; Dafr-Allah Benajah; Sidi Adil Ibrahimi; Chakib Nejjari; Mustapha Mahmoud; Abdellah Souleimani; Bahia Bennani
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.